scispace - formally typeset
M

Martin Heisig

Researcher at Yale University

Publications -  11
Citations -  450

Martin Heisig is an academic researcher from Yale University. The author has contributed to research in topics: Virus & Vaccinia. The author has an hindex of 9, co-authored 11 publications receiving 396 citations. Previous affiliations of Martin Heisig include University of Würzburg.

Papers
More filters
Journal ArticleDOI

The bacterial virulence factor InlC perturbs apical cell junctions and promotes cell-to-cell spread of Listeria

TL;DR: It is suggested that InlC promotes bacterial dissemination by relieving cortical tension, thereby enhancing the ability of motile bacteria to deform the plasma membrane into protrusions.
Journal ArticleDOI

Shigella mediated depletion of macrophages in a murine breast cancer model is associated with tumor regression.

TL;DR: Quantitative analysis of bacterial tumor targeting demonstrated that attenuated, invasive Shigella flexneri primarily infected TAMs after systemic administration, supporting TAMs as useful targets for antitumor therapy and highlighting attenuated bacterial pathogens as potential tools.
Journal ArticleDOI

Antivirulence properties of an antifreeze protein.

TL;DR: Data show that an antifreeze protein facilitates host control of bacterial infections and suggest therapeutic strategies for countering pathogens.
Journal ArticleDOI

Regression of Human Prostate Tumors and Metastases in Nude Mice following Treatment with the Recombinant Oncolytic Vaccinia Virus GLV-1h68

TL;DR: It is demonstrated that the GLV-1h68 virus has a great potential for treatment of human prostate carcinoma and led to strong inflammatory and oncolytic effects resulting in drastic reduction of regional lymph nodes with PC-3 metastases.